These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
897 related items for PubMed ID: 19686928
1. Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients. Thumbigere-Math V, Sabino MC, Gopalakrishnan R, Huckabay S, Dudek AZ, Basu S, Hughes PJ, Michalowicz BS, Leach JW, Swenson KK, Swift JQ, Adkinson C, Basi DL. J Oral Maxillofac Surg; 2009 Sep; 67(9):1904-13. PubMed ID: 19686928 [Abstract] [Full Text] [Related]
2. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws. Carlson ER, Basile JD. J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819 [Abstract] [Full Text] [Related]
3. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics. Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P. Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538 [Abstract] [Full Text] [Related]
4. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies. Assael LA. J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):35-43. PubMed ID: 19371813 [Abstract] [Full Text] [Related]
5. Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws. Dodson TB. J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):44-52. PubMed ID: 19371814 [Abstract] [Full Text] [Related]
6. Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan. Urade M, Tanaka N, Furusawa K, Shimada J, Shibata T, Kirita T, Yamamoto T, Ikebe T, Kitagawa Y, Fukuta J. J Oral Maxillofac Surg; 2011 Nov; 69(11):e364-71. PubMed ID: 21782307 [Abstract] [Full Text] [Related]
7. Management of patients on bisphosphonates and prevention of bisphosphonate-related osteonecrosis of the jaw. Chu V, American Association of Oral and Maxillofacial Surgeons, American Dental Association. Hawaii Dent J; 2008 Nov; 39(5):9-12; quiz 17. PubMed ID: 19189512 [Abstract] [Full Text] [Related]
8. Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates. Lazarovici TS, Mesilaty-Gross S, Vered I, Pariente C, Kanety H, Givol N, Yahalom R, Taicher S, Yarom N. J Oral Maxillofac Surg; 2010 Sep; 68(9):2241-7. PubMed ID: 20728033 [Abstract] [Full Text] [Related]
9. Resolution of oral bisphosphonate and steroid-related osteonecrosis of the jaw--a serial case analysis. Chiu CT, Chiang WF, Chuang CY, Chang SW. J Oral Maxillofac Surg; 2010 May; 68(5):1055-63. PubMed ID: 20403529 [Abstract] [Full Text] [Related]
20. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw - 2009 update. Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B, Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. Aust Endod J; 2009 Dec; 35(3):119-30. PubMed ID: 19961450 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]